• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子-κB 受体激活剂(RANK)及其在子宫内膜癌中的蛋白和基因水平与临床病理变量的关系研究。

Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.

机构信息

Research Unit on Women's Health-Institute of Health Research INCLIVA, 46010 Valencia, Spain.

Department of Pediatrics, Obstetrics and Gynecology, University of Valencia, 46010 Valencia, Spain.

出版信息

Int J Mol Sci. 2018 Jun 22;19(7):1848. doi: 10.3390/ijms19071848.

DOI:10.3390/ijms19071848
PMID:29932437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073139/
Abstract

The system integrated by the receptor activator of nuclear factor kappa B (RANK) and its ligand, RANKL, modulates the role of hormones in the genesis and progression of breast tumors. We investigated whether the expression of RANK was related with clinicopathological features of primary endometrial tumors. Immunohistochemistry was used in an endometrial cancer tissue array containing samples from 36 tumors. The amount of RANK mRNA was examined in a tissue scan cDNA array containing cDNA from 40 tumors. Normal endometrium was examined for comparison. Immunohistochemical analyses showed that RANK expression was higher in malignant than in normal endometrium ( < 0.05). RANK expression was related to histological grade (Pearson correlation index = 0.484, < 0.001), but not to tumor stage or to age of the women. The gene expression was similar in malignant and normal endometrium. The study of RANK isoforms confirmed that the overall relative abundance of the three clearly identified transcripts was similar in normal and pathological endometrium. RANK protein expression increased from normal to malignant endometrium, and the expression level was related with tumor grade but not with stage or the age of subjects in endometrial cancer. In contrast, similar comparisons showed no change in RANK gene expression.

摘要

核因子 κB 受体激活剂(RANK)及其配体 RANKL 构成的系统调节着激素在乳腺癌发生和发展中的作用。我们研究了 RANK 的表达是否与原发性子宫内膜肿瘤的临床病理特征有关。应用免疫组织化学方法检测了包含 36 例肿瘤样本的子宫内膜癌组织芯片中的 RANK 表达。采用组织扫描 cDNA 芯片检测了包含 40 例肿瘤 cDNA 的 RANK mRNA 量。同时检测了正常子宫内膜作为对照。免疫组化分析显示 RANK 在恶性肿瘤中的表达高于正常子宫内膜(<0.05)。RANK 的表达与组织学分级相关(皮尔逊相关指数=0.484,<0.001),但与肿瘤分期或患者年龄无关。在恶性和正常子宫内膜中基因表达相似。对 RANK 异构体的研究证实,在正常和病理性子宫内膜中,三种明确鉴定的转录本的总相对丰度相似。RANK 蛋白表达从正常子宫内膜增加到恶性子宫内膜,其表达水平与肿瘤分级相关,但与肿瘤分期或患者年龄无关。相比之下,相似的比较显示 RANK 基因表达没有变化。

相似文献

1
Receptor Activator of Nuclear Factor Kappa B (RANK) and Clinicopathological Variables in Endometrial Cancer: A Study at Protein and Gene Level.核因子-κB 受体激活剂(RANK)及其在子宫内膜癌中的蛋白和基因水平与临床病理变量的关系研究。
Int J Mol Sci. 2018 Jun 22;19(7):1848. doi: 10.3390/ijms19071848.
2
Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.RANK/RANKL通过AKT途径在子宫内膜癌中的临床预后意义及促转移活性
Oncotarget. 2016 Feb 2;7(5):5564-75. doi: 10.18632/oncotarget.6795.
3
WNT5A gene and protein expression in endometrial cancer.WNT5A基因与蛋白在子宫内膜癌中的表达
Folia Histochem Cytobiol. 2019;57(2):84-93. doi: 10.5603/FHC.a2019.0010. Epub 2019 Jun 14.
4
Expression of p53 in imprint smears of endometrial carcinoma.p53在子宫内膜癌印片涂片中的表达
Diagn Cytopathol. 2014 May;42(5):416-22. doi: 10.1002/dc.23056. Epub 2013 Oct 25.
5
Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue.原癌基因fos和jun在人子宫良性与恶性组织中的表达
Gynecol Oncol. 2000 Mar;76(3):388-96. doi: 10.1006/gyno.1999.5696.
6
[Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].[通过寡核苷酸微阵列分析HG-U133A评估子宫内膜腺癌女性中与组胺能系统相关基因的表达谱]
Ginekol Pol. 2014 Mar;85(3):172-9. doi: 10.17772/gp/1709.
7
RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.年轻乳腺癌患者及孕期的核因子κB受体活化因子配体(RANKL)表达情况。
Breast Cancer Res. 2015 Feb 21;17:24. doi: 10.1186/s13058-015-0538-7.
8
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.一种新型雌激素调节基因EIG121的鉴定,该基因由激素替代疗法诱导,在I型和II型子宫内膜癌中差异表达。
Clin Cancer Res. 2005 Dec 1;11(23):8258-64. doi: 10.1158/1078-0432.CCR-05-1189.
9
Hypomethylation-induced expression of S100A4 in endometrial carcinoma.子宫内膜癌中S100A4的低甲基化诱导表达
Mod Pathol. 2007 Oct;20(10):1045-54. doi: 10.1038/modpathol.3800940. Epub 2007 Aug 3.
10
Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein.人类子宫内膜的恶性转化与乳铁蛋白信使核糖核酸及蛋白质的过表达相关。
Cancer Res. 1995 Mar 1;55(5):1168-75.

引用本文的文献

1
Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers.组织学分级和肿瘤分期与上皮性卵巢癌中核因子 Kappa b 受体激活剂 (Rank) 的表达相关。
Int J Mol Sci. 2022 Feb 3;23(3):1742. doi: 10.3390/ijms23031742.
2
Macleaya cordata extracts exert antiviral effects in newborn mice with rotavirus-induced diarrhea via inhibiting the JAK2/STAT3 signaling pathway.博落回提取物通过抑制JAK2/STAT3信号通路对轮状病毒诱导腹泻的新生小鼠发挥抗病毒作用。
Exp Ther Med. 2020 Aug;20(2):1137-1144. doi: 10.3892/etm.2020.8766. Epub 2020 May 18.
3

本文引用的文献

1
RANKL/RANK: from bone loss to the prevention of breast cancer.核因子κB受体活化因子配体/核因子κB受体活化因子:从骨质流失到乳腺癌预防
Open Biol. 2016 Nov;6(11). doi: 10.1098/rsob.160230.
2
RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.RANK 信号阻断通过诱导肿瘤细胞分化减少乳腺癌复发。
Cancer Res. 2016 Oct 1;76(19):5857-5869. doi: 10.1158/0008-5472.CAN-15-2745. Epub 2016 Aug 1.
3
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.RANK 配体作为 BRCA1 突变携带者乳腺癌预防的潜在靶点。
Expression and function of Toll‑like receptors in peripheral blood mononuclear cells in patients with ankylosing spondylitis.
强直性脊柱炎患者外周血单个核细胞中 Toll 样受体的表达及功能。
Mol Med Rep. 2019 Oct;20(4):3565-3572. doi: 10.3892/mmr.2019.10631. Epub 2019 Sep 2.
Nat Med. 2016 Aug;22(8):933-9. doi: 10.1038/nm.4118. Epub 2016 Jun 20.
4
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.绝经后女性血清雌激素、雌激素代谢物与子宫内膜癌风险
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1081-9. doi: 10.1158/1055-9965.EPI-16-0225. Epub 2016 Apr 12.
5
CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells.CCL20介导RANK/RANKL诱导的子宫内膜癌细胞上皮-间质转化。
Oncotarget. 2016 May 3;7(18):25328-39. doi: 10.18632/oncotarget.8291.
6
RANK as a therapeutic target in cancer.RANK作为癌症的治疗靶点。
FEBS J. 2016 Jun;283(11):2018-33. doi: 10.1111/febs.13645. Epub 2016 Jan 28.
7
Clinical prognostic significance and pro-metastatic activity of RANK/RANKL via the AKT pathway in endometrial cancer.RANK/RANKL通过AKT途径在子宫内膜癌中的临床预后意义及促转移活性
Oncotarget. 2016 Feb 2;7(5):5564-75. doi: 10.18632/oncotarget.6795.
8
Progestogens and risk of breast cancer: a link between bone and breast?孕激素与乳腺癌风险:骨骼与乳腺之间的联系?
Gynecol Endocrinol. 2016;32(1):6-8. doi: 10.3109/09513590.2015.1078304. Epub 2015 Aug 21.
9
Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.内源性雌激素与乳腺癌、子宫内膜癌和卵巢癌的风险。
Steroids. 2015 Jul;99(Pt A):8-10. doi: 10.1016/j.steroids.2014.12.013. Epub 2014 Dec 30.
10
MPA influences tumor cell proliferation, migration, and invasion induced by RANKL through PRB involving the MAPK pathway in endometrial cancer.在子宫内膜癌中,甲泼尼龙通过涉及丝裂原活化蛋白激酶(MAPK)途径的孕激素受体B影响由核因子κB受体活化因子配体(RANKL)诱导的肿瘤细胞增殖、迁移和侵袭。
Oncol Rep. 2015 Feb;33(2):799-809. doi: 10.3892/or.2014.3651. Epub 2014 Dec 5.